Complete Genomics opens $3.2 million manufacturing facility at its San Jose headquarters

November 16, 2023 02:00 PM GMT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Complete Genomics opens $3.2 million manufacturing facility at its San Jose headquarters
Image source: Kalkine Media

SAN JOSE, Calif., Nov. 16, 2023 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, today announced plans for the opening of a $3.2 million manufacturing facility within its headquarters in San Jose, California. The facility, scheduled to open in March 2024, will give Complete Genomics customers access to a U.S.-based supply chain translating into faster delivery times for its next generation sequencing products.

The new facility will house Complete Genomics' research and development, engineering and ISO (International Organization for Standardization) manufacturing operations.

"In addition to giving Complete Genomics customers access to our first U.S.-based supply chain, the new manufacturing facility will be supported by local vendors and new hires in the form of operations and engineering staff to run it," said Dr. Radoje (Rade) Drmanac, Co-Founder and Chief Scientific Officer of Complete Genomics.

Complete Genomics was established in 2005 in a 10,500 square foot facility in Sunnyvale, California. In 2008, the company added a 66,000 square foot Mountain View site. In May 2017, Complete Genomics moved to its current 78,979 square foot location in San Jose, which also includes a warehousing facility.

Since the U.S. commercial launch of its DNBSEQ ™ sequencing product line in August 2022, Complete Genomics has announced integration partnerships with Integrated DNA Technologies and Basepair and was recognized by the 2023 R&D 100 Awards in the analytical testing category for its ultra-high throughput sequencer aimed at making whole genome sequencing (WGS) affordable for every lab. The DNBSEQ T20X2RS* was recently named "Next Generation Sequencing Solution of the Year" by the 2023 BioTech Breakthrough Awards.

About Complete Genomics

Complete Genomics is a pioneering life sciences company that provides novel, end to end DNA sequencing solutions. It has been at the forefront of high throughput cost-effective sequencing technology development since its inception in 2005. Our products have powered over 6,200 publications across a wide array of applications. To learn more, visit www.completegenomics.com.

* For Research Use Only. Not for use in diagnostic procedures.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

AI on the Rise: A Look at Top AI Companies and Their Stocks

Recent Articles

Investing Tips

Previous Next